Titre : Anticorps anti-cytoplasme des polynucléaires neutrophiles

Anticorps anti-cytoplasme des polynucléaires neutrophiles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Percutaneous Coronary Intervention
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anticorps anti-cytoplasme des polynucléaires neutrophiles : Questions médicales les plus fréquentes", "headline": "Anticorps anti-cytoplasme des polynucléaires neutrophiles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anticorps anti-cytoplasme des polynucléaires neutrophiles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-07", "dateModified": "2025-04-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anticorps anti-cytoplasme des polynucléaires neutrophiles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Marqueurs biologiques", "url": "https://questionsmedicales.fr/mesh/D015415", "about": { "@type": "MedicalCondition", "name": "Marqueurs biologiques", "code": { "@type": "MedicalCode", "code": "D015415", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.101" } } }, "about": { "@type": "MedicalCondition", "name": "Anticorps anti-cytoplasme des polynucléaires neutrophiles", "alternateName": "Antibodies, Antineutrophil Cytoplasmic", "code": { "@type": "MedicalCode", "code": "D019268", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ulrich Specks", "url": "https://questionsmedicales.fr/author/Ulrich%20Specks", "affiliation": { "@type": "Organization", "name": "Mayo Clinic, Rochester, Minnesota." } }, { "@type": "Person", "name": "Zachary S Wallace", "url": "https://questionsmedicales.fr/author/Zachary%20S%20Wallace", "affiliation": { "@type": "Organization", "name": "Massachusetts General Hospital, Boston." } }, { "@type": "Person", "name": "Xiaoqing Fu", "url": "https://questionsmedicales.fr/author/Xiaoqing%20Fu", "affiliation": { "@type": "Organization", "name": "Massachusetts General Hospital, Boston." } }, { "@type": "Person", "name": "Yuqing Zhang", "url": "https://questionsmedicales.fr/author/Yuqing%20Zhang", "affiliation": { "@type": "Organization", "name": "Massachusetts General Hospital, Boston." } }, { "@type": "Person", "name": "John H Stone", "url": "https://questionsmedicales.fr/author/John%20H%20Stone", "affiliation": { "@type": "Organization", "name": "Massachusetts General Hospital, Boston." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Peripheral Artery Disease Ultrasound Assessment in Predicting the Severity of Coronary Artery Disease.", "datePublished": "2024-03-01", "url": "https://questionsmedicales.fr/article/38541658", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/life14030333" } }, { "@type": "ScholarlyArticle", "name": "Large Coronary Cameral Fistula to the Left Ventricle Presenting as Congestive Heart Failure.", "datePublished": "2024-02-28", "url": "https://questionsmedicales.fr/article/38455689", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.12890/2024_004364" } }, { "@type": "ScholarlyArticle", "name": "Surgical Management of Anomalous Right Coronary Artery in the Adult: Technique and Case Series.", "datePublished": "2024-02-24", "url": "https://questionsmedicales.fr/article/38403570", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.hlc.2024.01.028" } }, { "@type": "ScholarlyArticle", "name": "Impact of Temperature and Atmospheric Pressure on Hospitalizations of Patients Presenting With Acute Coronary Syndrome.", "datePublished": "2024-02-24", "url": "https://questionsmedicales.fr/article/38533174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.54833" } }, { "@type": "ScholarlyArticle", "name": "Is ChatGPT knowledgeable of acute coronary syndromes and pertinent European Society of Cardiology Guidelines?", "datePublished": "2024-02-23", "url": "https://questionsmedicales.fr/article/38391252", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.23736/S2724-5683.24.06517-7" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Marqueurs biologiques", "item": "https://questionsmedicales.fr/mesh/D015415" }, { "@type": "ListItem", "position": 4, "name": "Anticorps anti-cytoplasme des polynucléaires neutrophiles", "item": "https://questionsmedicales.fr/mesh/D019268" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anticorps anti-cytoplasme des polynucléaires neutrophiles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anticorps anti-cytoplasme des polynucléaires neutrophiles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anticorps anti-cytoplasme des polynucléaires neutrophiles", "description": "Comment diagnostiquer la présence d'ANCA ?\nQuels tests sont utilisés pour les ANCA ?\nLes ANCA sont-ils toujours présents dans les maladies ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nLes ANCA peuvent-ils être détectés chez des personnes saines ?", "url": "https://questionsmedicales.fr/mesh/D019268?mesh_terms=Percutaneous+Coronary+Intervention&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anticorps anti-cytoplasme des polynucléaires neutrophiles", "description": "Quels sont les symptômes associés aux ANCA ?\nLes ANCA provoquent-ils des symptômes respiratoires ?\nY a-t-il des symptômes cutanés liés aux ANCA ?\nLes ANCA affectent-ils les reins ?\nLes symptômes des ANCA sont-ils similaires à d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D019268?mesh_terms=Percutaneous+Coronary+Intervention&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anticorps anti-cytoplasme des polynucléaires neutrophiles", "description": "Peut-on prévenir les maladies liées aux ANCA ?\nLes vaccinations sont-elles recommandées pour les patients ANCA ?\nComment réduire le risque de complications ?\nL'évitement de certains médicaments est-il conseillé ?\nLe stress influence-t-il les maladies ANCA ?", "url": "https://questionsmedicales.fr/mesh/D019268?mesh_terms=Percutaneous+Coronary+Intervention&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anticorps anti-cytoplasme des polynucléaires neutrophiles", "description": "Quels traitements sont utilisés pour les ANCA ?\nLes traitements sont-ils personnalisés pour chaque patient ?\nLes ANCA nécessitent-ils un suivi régulier ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements peuvent-ils guérir les ANCA ?", "url": "https://questionsmedicales.fr/mesh/D019268?mesh_terms=Percutaneous+Coronary+Intervention&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anticorps anti-cytoplasme des polynucléaires neutrophiles", "description": "Quelles sont les complications possibles des ANCA ?\nLes ANCA peuvent-ils entraîner des infections ?\nY a-t-il un risque de cancer associé aux ANCA ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications des ANCA ?", "url": "https://questionsmedicales.fr/mesh/D019268?mesh_terms=Percutaneous+Coronary+Intervention&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anticorps anti-cytoplasme des polynucléaires neutrophiles", "description": "Quels sont les facteurs de risque des ANCA ?\nLe sexe influence-t-il le risque d'ANCA ?\nL'âge joue-t-il un rôle dans le développement des ANCA ?\nCertaines professions augmentent-elles le risque d'ANCA ?\nLes infections antérieures sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D019268?mesh_terms=Percutaneous+Coronary+Intervention&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la présence d'ANCA ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test sanguin spécifique détecte les ANCA dans le sérum du patient." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les ANCA ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests ELISA et indirect immunofluorescence sont couramment utilisés." } }, { "@type": "Question", "name": "Les ANCA sont-ils toujours présents dans les maladies ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur présence varie selon la maladie et le stade de l'inflammation." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'historique aide à identifier les symptômes et les antécédents de maladies auto-immunes." } }, { "@type": "Question", "name": "Les ANCA peuvent-ils être détectés chez des personnes saines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des ANCA peuvent être présents à faible niveau chez des individus sains." } }, { "@type": "Question", "name": "Quels sont les symptômes associés aux ANCA ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, fièvre, perte de poids et douleurs articulaires." } }, { "@type": "Question", "name": "Les ANCA provoquent-ils des symptômes respiratoires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent causer des symptômes respiratoires comme la toux et l'essoufflement." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés liés aux ANCA ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées et des lésions peuvent apparaître chez certains patients." } }, { "@type": "Question", "name": "Les ANCA affectent-ils les reins ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent entraîner des atteintes rénales, comme la glomérulonéphrite." } }, { "@type": "Question", "name": "Les symptômes des ANCA sont-ils similaires à d'autres maladies ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être confondus avec d'autres maladies auto-immunes ou inflammatoires." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies liées aux ANCA ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un mode de vie sain aide." } }, { "@type": "Question", "name": "Les vaccinations sont-elles recommandées pour les patients ANCA ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent être recommandées pour prévenir les infections." } }, { "@type": "Question", "name": "Comment réduire le risque de complications ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et une gestion proactive des symptômes sont essentiels." } }, { "@type": "Question", "name": "L'évitement de certains médicaments est-il conseillé ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent aggraver les symptômes et doivent être évités." } }, { "@type": "Question", "name": "Le stress influence-t-il les maladies ANCA ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes et doit être géré efficacement." } }, { "@type": "Question", "name": "Quels traitements sont utilisés pour les ANCA ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes et les immunosuppresseurs sont souvent prescrits." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés pour chaque patient ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement est adapté en fonction de la gravité et des symptômes du patient." } }, { "@type": "Question", "name": "Les ANCA nécessitent-ils un suivi régulier ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier est essentiel pour ajuster le traitement et surveiller l'évolution." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent avoir des effets secondaires comme l'infection ou l'ostéoporose." } }, { "@type": "Question", "name": "Les traitements peuvent-ils guérir les ANCA ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de cure, mais les traitements peuvent contrôler les symptômes et la progression." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des ANCA ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des atteintes rénales, pulmonaires et cardiovasculaires." } }, { "@type": "Question", "name": "Les ANCA peuvent-ils entraîner des infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements immunosuppresseurs augmentent le risque d'infections." } }, { "@type": "Question", "name": "Y a-t-il un risque de cancer associé aux ANCA ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un risque accru de certains cancers chez les patients ANCA." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Comment surveiller les complications des ANCA ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers et des tests sanguins aident à surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque des ANCA ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, le tabagisme et certaines infections." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque d'ANCA ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus souvent touchées par les maladies associées aux ANCA." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le développement des ANCA ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les ANCA apparaissent généralement chez les adultes jeunes à moyens d'âge." } }, { "@type": "Question", "name": "Certaines professions augmentent-elles le risque d'ANCA ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les professions exposant à des produits chimiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections antérieures sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent déclencher la production d'ANCA chez des individus prédisposés." } } ] } ] }

Sources (10000 au total)

Large Coronary Cameral Fistula to the Left Ventricle Presenting as Congestive Heart Failure.

A 56-year-old African American female was under evaluation for coronary artery disease by a cardiologist due to her complaints of intermittent chest pain. She underwent an outpatient echocardiogram an... A description of rare coronary anomalies adds to the fund of medical knowledge and can guide physicians to make evidence-based decisions regarding its management.Increasing description of coronary cam...

Surgical Management of Anomalous Right Coronary Artery in the Adult: Technique and Case Series.

The management of adult patients with anomalous aortic origin of the right coronary artery (ARCA) from the left aortic sinus poses important challenges. The presence of symptoms or documented ischaemi... A retrospective review was performed of all cases of surgical management of ARCA at a single centre. The primary endpoints were mortality and myocardial infarction at 30 days. Secondary endpoints incl... From October 2019 to August 2023, 15 adult patients underwent surgery for ARCA; 13 patients were included in this study (mean age 53.9±11.1 years; 10 female). A slit-like orifice, a long intramural se... Surgical unroofing of anomalous coronary artery in the adult is safe and effective; correction of both the slit-like orifice and intramural portion of the anomaly provides a durable result in patients...

Impact of Temperature and Atmospheric Pressure on Hospitalizations of Patients Presenting With Acute Coronary Syndrome.

This study aims to investigate the impact of temperature and atmospheric pressure on hospitalizations of patients with acute coronary syndrome (ACS).... This is a retrospective, observational, analytical study conducted in a single center, University Hospital Center "Mother Teresa," Tirana, Albania, in the period January-December 2018. This study incl... The study involved 1,165 patients, with a mean age of 63.1 years, ranging from 27 years to 89 years old. The majority of patients (78.6%) were male, while 21.4% were female. A statistically significan... An important relationship between seasonal, monthly, and daily changes in temperature and atmospheric pressure concerning the frequency of cases with ACS was observed....

Is ChatGPT knowledgeable of acute coronary syndromes and pertinent European Society of Cardiology Guidelines?

Advancements in artificial intelligence are being seen in multiple fields, including medicine, and this trend is likely to continue going forward. To analyze the accuracy and reproducibility of ChatGP... The questions asked to ChatGPT were prepared in two categories. A list of frequently asked questions (FAQs) created from inquiries asked by the public and while preparing the scientific question list,... Eventually, 72 FAQs related to ACS met the study inclusion criteria. In total, 65 (90.3%) ChatGPT answers scored GQS 5, which indicated highest accuracy and proficiency. None of the ChatGPT responses ... This study shows for the first time that ChatGPT can give accurate and sufficient responses to more than 90% of FAQs about ACS. In addition, proficiency and correctness of ChatGPT answers about questi...

The association between growth differentiation factor 15 and presence and severity of coronary atherosclerosis.

Growth differentiation factor 15 (GDF-15) is a member of the transforming growth factor beta superfamily and is faintly expressed under healthy conditions. GDF-15 is markedly elevated in a variety of ... We enrolled 129 patients undergoing coronary angiography for the evaluation of stable CAD in the study. SYNTAX and SYNTAX II PCI/CABG scores were calculated. The CAD (+) study group was also stratifie... Of the 129 patients, 75 had CAD. GDF-15 values were higher in the CAD (+) group (p ​< ​0.001). The two groups were compared according to a cut-off value of 2451.77. SYNTAX and SYNTAX II PCI/CABG score... GDF-15 is an independent predictor of CAD and is associated with CAD severity in terms of SYNTAX, SYNTAX II PCI and SYNTAX II CABG scores....

Exercise-induced cardiac troponin release in athletes with versus without coronary atherosclerosis.

The magnitude of exercise-induced cardiac troponin (cTn) elevations is dependent on cardiovascular health status, and previous studies have shown that occult coronary atherosclerosis is highly prevale... We included 59 male athletes from the MARC-2 study and stratified them as controls (coronary artery calcium score (CACS) = 0, n=20), high CACS (≥300 Agatston Units or ≥75th MESA percentile, n=20) or s... 58 participants (61 [58-69] years) completed the exercise test (76±14 minutes) with a peak heart rate of 97.7 [94.8-101.8]% of their estimated maximum. Exercise duration and workload did not differ ac... Serial sampling of hs-cTnT and hs-cTnI concentrations during and following an exhaustive endurance exercise test did not reveal differences in exercise-induced cTn release between athletes with...

Temporal biomarker concentration patterns during the early course of acute coronary syndrome.

Biomarker concentrations and their changes during acute coronary syndrome (ACS) provide clinically useful information on pathophysiological processes, e.g. myocardial necrosis, hemodynamic stress and ... We measured concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and I (hs-cTnI), NT-terminal pro-B-type natriuretic peptide, C-reactive protein, and growth-differentiation factor-15 (GDF-1... The study population consisted of 16,944 patients (median age 62 years; 71.3 % males) with 6,853 (40.3 %) having ST-elevation myocardial infarction (STEMI) and 10,141 (59.7 %) having non-ST-elevation ... Temporal concentration patterns differ for various biomarkers early during ACS, reflecting the variability in the activation and duration of different pathophysiological processes, and the amount of i...

Left coronary sinus of valsalva aneurysm dissecting into interventricular septum: a case report.

Sinus of Valsalva aneurysm (SVA) is an extremely rare condition, and its rupture causes acute symptoms such as chest pain and dyspnea. Ruptured SVA is frequently associated with other congenital defec... A 37-year-old male presented with SVA originating from the left coronary sinus that ruptured into the interventricular septum. SVA was diagnosed by echocardiography, cardiac computed tomography and ma... SVA is a rare cardiac abnormality which can lead to severe clinical symptoms upon rupture. Immediate surgery is necessary to repair the ruptured SVA....

ANOCA patients with and without coronary vasomotor dysfunction present with limited electrocardiographic remodeling.

Coronary vasomotor dysfunction (CVDys) comprises coronary vasospasm (CVS) and/or coronary microvascular dysfunction (CMD) and is highly prevalent in patients with angina and non-obstructive coronary a... We collected pre-procedural 12-lead electrocardiograms of ANOCA patients with CVS (n = 35), CMD (n = 24), CVS/CMD (n = 26) and patients without CVDys (CFT-, n = 23) who participated in the NL-CFT regi... Heart axis, heart rate, PQ interval and QRS duration were comparable between the groups. A small prolongation of the QT-interval corrected with Bazett (QTcB) and Fridericia (QTcF) was observed in pati... Pre-procedural 12-lead electrocardiograms were comparable between patients with and without CVDys undergoing CFT except for a slightly longer QTc interval in patients with CVDys compared to patients w...